Why Are These 3 Vanguard ETFs Underperforming the S&P 500 Since Election Day?
The S&P 500 rallied in the wake of last week's election results, climbing 3.8% since Nov. 5 at Wednesday's prices. But not ...
Barchart on MSN19h
Is Wall Street Bullish or Bearish on Amgen Stock?
Amgen Inc. (AMGN), headquartered in Thousand Oaks, California, discovers, develops, manufactures, and delivers human ...
Organon: 7% Yield, 4x P/E, Big Upside Potential
Organon is a strong investment opportunity with a high yield, diversified portfolio, steady performance, and transformative ...
Friday's big stock stories: What’s likely to move the market in the next trading session
Stocks slid on Thursday as Fed Chair Jerome Powell signaled that policymakers don't need to be in a hurry to cut rates.
PTC Therapeutics wins FDA nod for gene therapy
PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...
This biotech's stock could double if its treatment for major depressive disorder succeeds, says Mizuho
Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...
Biogen, Eisai Win CHMP Backing of Leqembi Alzheimer's Drug
A key European regulatory panel has reversed course and is now recommending approval of Leqembi, the Alzheimer's drug from Biogen and Eisai. The companies on Thursday said the European Medicines ...